BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2733846)

  • 21. Carcinoma of the thyroid.
    Fitchett CW; Carraway JH
    Va Med Mon (1918); 1970 Jul; 97(7):422-5. PubMed ID: 5528011
    [No Abstract]   [Full Text] [Related]  

  • 22. Cause of death in patients with well-differentiated thyroid carcinoma.
    Beasley NJ; Walfish PG; Witterick I; Freeman JL
    Laryngoscope; 2001 Jun; 111(6):989-91. PubMed ID: 11404609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic index in cancer of the thyroid gland].
    Lukomskiĭ GI; Ivanova NA; Kabanova GM; Seredin VP
    Vestn Khir Im I I Grek; 1988 Feb; 140(2):3-6. PubMed ID: 3388705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in patients with differentiated thyroid carcinoma.
    Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
    Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of node-picking lymphadenectomy in the treatment of differentiated carcinoma of the thyroid].
    Nicolosi A; Malloci A; Esu S; Addis E; Tarquini A
    Minerva Chir; 1993 May; 48(9):459-63. PubMed ID: 8355874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute.
    Chow SM; Law SC; Au SK; Leung TW; Chan PT; Mendenhall WM; Lau WH
    Head Neck; 2002 Jul; 24(7):670-7. PubMed ID: 12112541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.
    Brierley J; Tsang R; Panzarella T; Bana N
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma.
    Scheumann GF; Seeliger H; Musholt TJ; Gimm O; Wegener G; Dralle H; Hundeshagen H; Pichlmayr R
    Eur J Surg; 1996 Sep; 162(9):677-84. PubMed ID: 8908447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
    Obiols G; Simó R; Burgos R; Tresserras R; Galofré P; Masmiquel L; Hernández C; Mesa J
    Med Clin (Barc); 1997 Nov; 109(19):738-43. PubMed ID: 9470182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surgical therapy of differentiated thyroid gland carcinoma].
    Walgenbach S; Sternheim E; Bittinger F; Junginger T
    Zentralbl Chir; 1997; 122(4):252-8. PubMed ID: 9221635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
    Mathonnet M
    Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Flow cytometric DNA measurements of thyroid carcinomas].
    Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
    Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multifactorial prognostic analysis in the surgical treatment of well differentiated thyroid neoplasms].
    Zani B; Tirone G; Valduga P; Silvestri M; Eccher C
    Minerva Chir; 2002 Aug; 57(4):475-9. PubMed ID: 12145578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multivariate study of prognostic factors for differentiated thyroid carcinoma: the significance of histologic subtype.
    Noguchi M; Mizukami Y; Michigishi T; Koyasaki N; Ohta N; Miyazaki I
    Int Surg; 1993; 78(1):10-5. PubMed ID: 8473075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The value of quantitative DNA analysis in evaluating the prognosis of differentiated thyroid cancer].
    Böttger T; Potratz D; Schernus B; Klupp J; Stöckle M; Junginger T
    Chirurg; 1994 Mar; 65(3):190-3. PubMed ID: 8194403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of "locally advanced" well-differentiated thyroid carcinomas.
    Falvo L; Catania A; Grilli P; Di Matteo FM; De Antoni E
    Ann Ital Chir; 2004; 75(1):17-21. PubMed ID: 15283382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.